Table 3.
The potential of Soshihotang as a treatment option for COVID-19.
Effects of Soshihotang | Contents | Expected effects in COVID-19 |
---|---|---|
Anti-SARS-CoV-2 activity57 | Components of soshihotang show Anti-SARS-CoV-2 activity (baicalein, beta-carotene, coptisine, formononetin, glycyrrhizic acid, kaempferol, moupinamide, quercetin, saikosaponin A, saikosaponin B2, saikosaponin D, and 7-methoxy-2-methyl isoflavone) | Inhibition of SARS-CoV-2 activity |
Immunomodulatory effect58 | Soshihotang increases lymphocytes only in the immunosuppressive model (invalid in the normal animal model) | Correction of early lymphocyte degradation in patients with COVID-19 |
Hepato-protective effects15, 16, 17, 18, 19, 20, 21, 25 | Soshihotang has been utilized in patients with HBV or HCV infection and has shown significant antiviral and hepato-protective effects | Management of liver injury in patients with COVID-19 |
COVID-19; coronavirus disease 2019.
HBV; Hepatitis B virus.
HCV; Hepatitis C virus.